Company Quick10K Filing
SPAR Group
Price0.69 EPS0
Shares21 P/E2
MCap15 P/FCF9
Net Debt6 EBIT9
TEV20 TEV/EBIT2
TTM 2019-09-30, in MM, except price, ratios
10-Q 2020-12-31 Filed 2021-02-08
10-K 2020-12-31 Filed 2021-03-31
10-Q 2020-09-30 Filed 2021-02-05
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-08-14
10-K 2020-06-30 Filed 2021-01-20
10-Q 2020-03-31 Filed 2020-05-15
10-Q 2020-03-31 Filed 2020-06-29
10-Q 2019-12-31 Filed 2020-02-12
10-K 2019-12-31 Filed 2020-04-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-15
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-13
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-02
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-10
10-Q 2012-03-31 Filed 2012-05-11
10-K 2011-12-31 Filed 2012-03-21
10-Q 2011-09-30 Filed 2011-11-07
10-Q 2011-06-30 Filed 2011-08-05
10-Q 2011-03-31 Filed 2011-05-10
10-K 2010-12-31 Filed 2011-03-15
10-Q 2010-11-10 Filed 2010-11-12
10-Q 2010-08-11 Filed 2010-08-11
10-Q 2010-03-31 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-04-15
8-K 2020-08-04
8-K 2020-07-31
8-K 2020-07-16
8-K 2020-05-28
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-05-06
8-K 2020-05-01
8-K 2020-04-30
8-K 2020-04-29
8-K 2020-04-23
8-K 2020-04-23
8-K 2020-03-27
8-K 2020-03-27
8-K 2020-01-18
8-K 2019-12-31
8-K 2019-12-10
8-K 2019-12-06
8-K 2019-10-14
8-K 2019-09-10
8-K 2019-09-04
8-K 2019-09-03
8-K 2019-08-20
8-K 2019-08-14
8-K 2019-08-08
8-K 2019-08-06
8-K 2019-07-25
8-K 2019-06-11
8-K 2019-05-15
8-K 2019-05-15
8-K 2019-05-01
8-K 2019-02-05
8-K 2019-01-18
8-K 2018-12-10
8-K 2018-11-28
8-K 2018-11-20
8-K 2018-11-19
8-K 2018-09-21
8-K 2018-09-04
8-K 2018-08-20
8-K 2018-06-29
8-K 2018-05-23
8-K 2018-05-15
8-K 2018-05-07
8-K 2018-05-02
8-K 2018-05-02
8-K 2018-04-02
8-K 2018-01-16
8-K 2018-01-09

SGRP 10Q Quarterly Report

Part I &Mdash; Financial Information
Item 1. Financial Statements
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Item 4. Controls and Procedures.
Part II. Other Information
Item 1. Legal Proceedings.
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Item 3. Defaults Upon Senior Securities.
Item 4. Mine Safety Disclosures.
Item 5. Other Information.
Item 6. Exhibits
EX-31.1 exhibit31-1.htm
EX-31.2 exhibit31-2.htm
EX-32.1 exhibit32-1.htm
EX-32.2 exhibit32-2.htm

SPAR Group Earnings 2020-12-31

Balance SheetIncome StatementCash Flow
907254361802012201420172020
Assets, Equity
7055412712-12012201420172020
Rev, G Profit, Net Income
10.06.02.0-2.0-6.0-10.02012201420172020
Ops, Inv, Fin

10-Q 1 sgrp-20201231_10q.htm SIGMARENOPRO INC

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the quarterly period ended December 31, 2020

 

Or

 

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from __________ to __________ 

    

Commission File Number:  333-221302

SIGMARENOPRO INC.

(Exact name of registrant as specified in its charter)

 

Nevada   2821   38-4045138
(State or Other Jurisdiction of   (Primary Standard Industrial   (IRS Employer
Incorporation or Organization)   Classification Number)   Identification Number)

 

SigmaRenoPro, Inc.

Aloni Noa’kh St. 1
Kiryat Motzkin 26402

Israel
+972 03-6860331

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ ] No [ X]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

 

See the definitions of "large accelerated filer," "accelerated filer," "non-accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [ ]   Accelerated filer [ ]
Non-accelerated filer [ ]   Smaller reporting company [ X ]
(Do not check if a smaller reporting company)    

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [X] No []

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as February 05, 2021, is 4,500,000 shares.

 

1 

 

 

 

SIGMARENOPRO INC.

 

  PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements 3
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 4
Item 3. Quantitative and Qualitative Disclosures about Market Risk 7
Item 4. Controls and Procedures 7
     
  PART II – OTHER INFORMATION  
     
Item 1. Legal Proceedings 8
Item 1A. Risk Factors 8
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 8
Item 3. Defaults Upon Senior Securities 8
Item 4. Mine Safety Disclosures 8
Item 5. Other Information 8
Item 6. Exhibits 8
     
Signature   9

 

 

2 

 

 

 

 

SIGMARENOPRO INC.

  

 

PART I — FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

   
INDEX TO UNAUDITED FINANCIAL STATEMENTS PAGE
   
Balance Sheets at December 31 , 2020 and June 30, 2020 (Audited) F-1
   
  Statements of Operations for the three and six months periods ended December 31, 2020 and 2019 (Unaudited) F-2
   
Statements of Stockholders’ Deficit for the three and six months ended December 31, 2020 and 2019 (Unaudited) F-3
   
  Statements of Cash Flows for the six month periods ended December 31, 2020 and 2019 (Unaudited) F-4
   
Notes to Unaudited Financial Statements F-5

 

3 

 

  

Sigmarenopro, Inc
Balance Sheets
       
   December 31,  June 30,
   2020  2020
   (Unaudited)  (Audited)
ASSETS          
Current assets          
Cash held in trust  $10,256   $5,566 
Prepaid expenses   162    838 
Total current assets   10,418    6,404 
Total assets  $10,418   $6,404 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current liabilities          
Due to related parties  $16,000   $6,000 
Short term fund   4,116    4,116 
Accounts payable   9,166    5,607 
Total current liabilities  $29,282   $15,723 
           
Commitments and contingencies          
           
STOCKHOLDERS’ EQUITY:          
Common stock: $0.001 par value, 75,000,000 shares authorized, 4,500,000 and 4,500,000 shares issued and outstanding as of December 31, 2020 and June 30, 2020, respectively   4,500   $4,500 
Additional paid-in capital   68,900    68,900 
Accumulated deficit   (92,264)   (82,719)
Total stockholders’ equity (deficit)   (18,864)   (9,319)
           
Total liabilities and stockholders’ equity  $10,418   $6,404 
           
The accompanying notes are an integral part of these financial statements.

  

F-1 

 

 

 

Sigmarenopro, Inc
Statements of Operations
(Unaudited)
   For the three months ended December 31,  For the three months ended December 31,  For the six months ended December 31,  For the six months ended December 31,
   2020  2019  2020  2019
           (Restated) 
                     
REVENUE:  $—     $—     $—     $—   
EXPENSES:                    
   General and Administrative Expenses   68    45    136    5,304 
Professional fees   5,568    3,403    8,809    8,894 
Share transfer agent fee   300    205    600    205 
Total expenses  $5,936   $3,653   $9,545   $14,403 
NET LOSS  $(5,936)  $(3,653)  $(9,545)  $(14,403)
Net loss per common share - basic  $(0.001)  $(0.0008)  $(0.002)  $(0.0032)
Weighted average of common shares outstanding - basic   4,500,000    4,500,000    4,500,000    4,500,000 
                     
The accompanying notes are an integral part of these financial statements.

 

 

F-2 

 

  

Sigmarenopro, Inc
Statement of Stockholders’ Deficit
(Unaudited)
For the three and six months ended December 31, 2019
                
   Common Stock  Additional Paid-in  Accumulated  Total Stockholders’
   Shares  Amount  Capital  Deficit  Deficit
Balance at September 30, 2019   4,500,000   $4,500   $68,900   $(65,851)  $7,549 
Net loss for the  three months ended December 31, 2019   —      —      —      (3,653)   (3,653)
Balance at December 31, 2019   4,500,000   $4,500   $68,900   $(69,504)  $3,896 
                          
    Common Stock    Additional Paid-in    Accumulated    Total Stockholders’ 
    Shares    Amount    Capital    Deficit    Deficit 
Balance at June 30, 2019   4,500,000   $4,500   $68,900   $(55,101)  $18,299 
Net loss for the six months ended December 31, 2019   —      —      —      (14,403)   (14,403)
Balance at December 31, 2019   4,500,000   $4,500   $68,900   $(69,504)  $3,896 
                

 

Sigmarenopro, Inc
Statement of Stockholders’ Deficit
(Unaudited)
For the three and six months ended December 31, 2020
                
   Common Stock  Additional Paid-in  Accumulated  Total Stockholders’
   Shares  Amount  Capital  Deficit  Deficit
Balance at September 30, 2020   4,500,000   $4,500   $68,900   $(86,328)  $(12,928)
Net loss for the  three months ended December 31, 2020   —      —      —      (5,936)   (5,936)
Balance at December 31, 2020   4,500,000   $4,500   $68,900   $(92,264)  $(18,864)
                          
    Common Stock    Additional Paid-in    Accumulated    Total Stockholders’ 
    Shares    Amount    Capital    Deficit    Deficit 
Balance at June 30, 2020   4,500,000   $4,500   $68,900   $(82,719)  $(9,319)
Net loss for the six months ended December 31, 2020   —      —      —      (9,545)   (9,545)
Balance at December 31, 2020   4,500,000   $4,500   $68,900   $(92,264)  $(18,864)
                          
The accompanying notes are an integral part of these financial statements.

 

F-3 

 

 

 

Sigmarenopro, Inc
Statement of Cash Flows 
(Unaudited)
       
   For the six months ended December 31,  For the six months ended December 31,
   2020  2019
      (Restated)
       
Cash Flow from Operating Activities:          
Net loss  $(9,545)  $(14,403)
Changes in Operating Assets and Liabilities:          
Increase (Decrease) in advances   —      4,638 
(Increase) Decrease in prepaid expenses   676    2,294 
Increase (Decrease) in accounts payable   3,559    100 
Net cash used in operating activities  $(5,310)  $(7,371)
           
Cash flows from Investing Activities:          
Net cash provided by investing activities  $—     $—   
           
Cash flows from Financing Activities:          
    Proceeds from related party debt   10,000    —   
Net cash provided by financing activities  $10,000   $—   
           
Net increase in cash, cash equivalents, and restricted cash   4,690    (7,371)
Cash, cash equivalents, and restricted cash at beginning of year   5,566    17,367 
Cash, cash equivalents, and restricted cash at end of year  $10,256   $9,996 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid for interest  $—     $—   
Cash paid for income taxes  $—     $—   
           
The accompanying notes are an integral part of these financial statements.

 

F-4 

 

 

 

SIGMARENOPRO, INC.

NOTES TO UNAUDITED FINANCIAL STATEMENTS

DECEMBER 31, 2020

 

NOTE A – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

A summary of significant accounting policies of Sigmarenopro, Inc. (the Company) is presented to assist in understanding the Company’s financial statements. The accounting policies presented in these footnotes conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements. These financial statements and notes are representations of the Company’s management who are responsible for their integrity and objectivity. The Company has not realized revenues from its planned principal business purpose.

 

Organization, Nature of Business and Trade Name

 

Sigmarenopro, Inc. (the Company) was incorporated in the State of Nevada on June 16, 2017. Sigmarenopro, Inc. intends to provide home project owners with contractor match making services in the U.S. Their customized match making service helps homeowners converge with professional contractors. They also intend to create a collection of articles intended to help homeowners with home project information, including how to outline project requirements, select the right contractor, interview contractors, draw up a project contract and settle disputes with contractors. Their service is deigned to be free for all homeowners to use and post their projects and plan to build a network of professionally-skilled contractors who provide a broad array of construction and renovation services for everything from changing light fixtures to complete kitchen renovation, and from housecleaning services to new construction.

The Company’s principal office is in Kiryat Motzkin, Israel.

 

The Company’s activities are subject to significant risks and uncertainties including failing to secure additional funding to operationalize the Company’s website and apps before another company develops similar websites or apps.

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows at December 31, 2020 and for the related periods presented.

 

Property and Equipment

 

Property and equipment are carried at cost. Expenditures for maintenance and repairs are charged against operations. Renewals and betterments that materially extend the life of the assets are capitalized. When assets are retired or otherwise disposed of, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is reflected in income for the period.

 

Depreciation is computed for financial statement purposes on a straight-line basis over estimated useful lives of the related assets. The estimated useful lives of depreciable assets are:

 

  Estimated Useful Lives
Office Equipment 5-10 years
Copier 5-7   years
Vehicles 5-10 years

 

For federal income tax purposes, depreciation is computed under the modified accelerated cost recovery system. For financial statements purposes, depreciation is computed under the straight-line method.

 

The Company has been in the developmental stage since inception and has no operations to date. The Company currently does not have any property and equipment. The above accounting policies will be adopted upon the Company maintains property and equipment.

 

F-5 

 

 

Cash and Cash Equivalents

 

For purposes of the statement of cash flows, the Company considers all short-term debt securities purchased with maturity of three months or less to be cash equivalents.

 

Recent Accounting Pronouncements

 

We have reviewed all the recently issued, but not yet effective, accounting pronouncements and we do not believe any of these pronouncements will have a material impact on the Company.

 

Revenue recognition

 

The Company’s revenue recognition policies are in compliance with FASB ASC 605-35 “Revenue Recognition”.  Revenue is recognized when a formal arrangement exists, the price is fixed or determinable, all obligations have been performed pursuant to the terms of the formal arrangement and collectability is reasonably assured.  The Company recognizes revenues on sales of its services, based on the terms of the customer agreement.  The customer agreement takes the form of either a contract or a customer purchase order and each provides information with respect to the service being sold and the sales price.  If the customer agreement does not have specific delivery or customer acceptance terms, revenue is recognized at the time the service is provided to the customer.

 

Fair Value of Financial Instruments

 


The Company applies fair value accounting for all financial assets and liabilities and non-financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

 

In accordance with the fair value accounting requirements, companies may choose to measure eligible financial instruments and certain other items at fair value. The Company has not elected the fair value option for any eligible financial instruments.

 

As of December 31, 2020, the carrying value of loans that are required to be measured at fair value, approximated fair value due to the short-term nature and maturity of these instruments.

 

F-6 

 

 

Advertising

 

Advertising expenses are recorded as general and administrative expenses when they are incurred.

 

Use of Estimates

 

The preparation of financial statements in accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  A change in managements’ estimates or assumptions could have a material impact on Sigmarenopro, Inc.’s financial condition and results of operations during the period in which such changes occurred. Actual results could differ from those estimates. Sigmarenopro, Inc.’s financial statements reflect all adjustments that management believes are necessary for the fair presentation of their financial condition and results of operations for the periods presented.

 

Capital Stock

 

The Company has authorized Seventy Five Million (75,000,000) shares of common stock with a par value of $0.001. Four Million Five Hundred and Thousand (4,500,000) shares of common stock were issued and outstanding as of December 31, 2020.

 

Income Taxes

 

The Company recognizes the tax effects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reported for tax purposes.

 

NOTE B – GOING CONCERN

 

The Company's financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, the Company does not have an established source of revenues sufficient to cover its operating costs and to allow it to continue as a going concern.

 

Under the going concern assumption, an entity is ordinarily viewed as continuing in business for the foreseeable future with neither the intention nor the necessity of liquidation, ceasing trading, or seeking protection from creditors pursuant to laws or regulations. Accordingly, assets and liabilities are recorded on the basis that the entity will be able to realize its assets and discharge its liabilities in the normal course of business.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the Business paragraph and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern. 

 

During the next year, the Company’s foreseeable cash requirements will relate to continual development of the operations of its business, maintaining its good standing and making the requisite filings with the Securities and Exchange Commission, and the payment of expenses associated with app development. The Company may experience a cash shortfall and be required to raise additional capital.

 

Historically, it has mostly relied upon internally generated funds and funds from the sale of shares of stock to finance its operations and growth. Management may raise additional capital through future public or private offerings of the Company’s stock or through loans from private investors, although there can be no assurance that it will be able to obtain such financing. The Company’s failure to do so could have a material and adverse effect upon it and its shareholders.

 

In the past year, the Company funded operations by using cash proceeds received through the issuance of common stock. For the coming year, the Company plans to continue to fund the Company through debt and securities sales and issuances until the company generates enough revenues through the operations as stated above.

 

F-7 

 

 NOTE C – COMMON STOCK

 

On June 2017, Company issued 1,150,000 Common Shares to the director of the company at $0.008 per share for cash proceeds of $9,200.

 

On June 2017, Company issued 1,150,000 common shares to the secretary of the company at $0.008 per share for cash proceeds of $9,200.

 

On April 2018, Company issued 560,000 common shares to the various shareholder of the company at $0.025 per share for cash proceeds of $14,000.

 

On May 2018, Company issued 640,000 common shares to the various shareholder of the company at $0.025 per share for cash proceeds of $16,000.

 

On June 2018, Company issued 1,000,000 common shares to the various shareholder of the company at $0.025 per share for cash proceeds of $25,000.

 

There were 4,500,000 and 4,500,000 shares of common stock issued and outstanding as of December 31, 2020 and June 30, 2020 respectively.

 

NOTE D – RELATED PARTY TRANSACTIONS

 

On June 2017, Company issued 1,150,000 Common Shares to the director of the company at $0.008 per share for cash proceeds of $9,200. (Refer Note C)

 

On June 2017, Company issued 1,150,000 Common Shares to the secretary of the company at $0.008 per shares for cash proceeds of $9,200. (Refer Note C)

 

The Company received loans from Aamar Omar, Director of the Company towards various operating expenses. During the year ended June 30, 2018 and 2019, the Company received a loan totaling $5,000 and $1,000 towards operating expenses. The loans are unsecured, non-interest bearing and due on demand.

 

During the quarter ended December 31, 2020, the Company received loans from Aamar Omar, Director of the Company totaling $10,000 towards operating expenses. The loans are unsecured, non-interest bearing and due on demand.

 

As of December 31,2020 and June 30, 2020, $16,000 and $6,000 respectively was due to Aamar Omar, Director of the Company.

 

NOTE E – TRUST ACCOUNT

 

Trust account (cash equivalent) is held by a law firm which provides periodic statement and pay the bills on behalf of Sigmarenopro. Law firm charges fees for managing the trust account

 

NOTE F – PREPAID EXPENSES

 

Prepaid expenses for the three months ending December 31, 2020 consist of $100 towards share transfer fee expenses paid to Globex, $62 towards registered agent fees and June 30, 2020 consists of $700 towards share transfer fee expenses paid to Globex, $138 towards registered agent fees.

 

Prepaid expenses as of December 31, 2020 and June 30, 2020 is $162 and $838 respectively.

 

NOTE G – SHORT TERM FUND

 

Company engaged Mussa Dahoud, to sell services to the prospective customers and deposit the money in the company escrow account. During the three months ended June 30, 2020 total amount of $ 4,116 was deposited by him. Since Mussa Dahoud, didn’t provide the full list of prospective customer details, it’s held as short-term fund. Company will return the fund to the agent Mussa Dahoud, if he fails to provide the correct customer information. 

F-8 

 

 

NOTE H – RESTATEMENT

 

The following are previously recorded and restated balances as of December 31, 2019, for the year ended June 30,2020.

 

Sigmarenopro, Inc
Balance Sheets
          
   December 31,  December 31,  December 31,
   2019  2019  2019
   (As Previously Reported)  (Restatement Adjustments)  (As Restated)
ASSETS               
Current assets               
Cash held in trust  $9,996   $—     $9,996 
Prepaid expenses   —      —      —   
Advances   —      —      —   
Total current assets   9,996    —      9,996 
Total assets  $9,996   $—     $9,996 
                
LIABILITIES AND STOCKHOLDERS' EQUITY               
Current liabilities               
      Accounts payable   100    —      100 
Due to related parties  $5,000   $1,000   $6,000 
Total current liabilities  $5,100   $1,000   $6,100 
                
Commitments and contingencies               
                
STOCKHOLDERS’ EQUITY:               
Common stock: $0.001 par value, 75,000,000 shares authorized, 4,500,000 and 4,500,000 shares issued and outstanding as of December 31, 2019, respectively  $4,500   $—     $4,500 
Additional paid-in capital   68,900    —      68,900 
Accumulated deficit   (64,504)   (5,000)   (69,504)
Total stockholders’ equity (deficit)   4,896    (5,000)   3,896 
                
Total liabilities and stockholders’ equity  $9,996   $(4,000)  $9,996 
                
                
The accompanying notes are an integral part of these financial statements.

 

F-9 

 

  

Sigmarenopro, Inc
Statements of Operations
          
   For the six months ended December 31,  For the six months ended December 31,  For the six months ended December 31,
   2019  2019  2019
   (As Previously Reported)  (Restatement Adjustments)  (As Restated)
          
REVENUE:  $—     $—     $—   
                
EXPENSES:               
   General and Administrative Expenses   45    5,259    5,304 
Professional fees   9,515    (621)   8,894 
Stock transfer fees   205    —      205 
Total expenses  $9,765   $4,638   $14,403 
                
NET LOSS  $(9,765)  $(4,638)  $(14,403)
                
Net loss per common share - basic  $(0.00)  $(0.00)  $(0.00)
Weighted average of common shares outstanding - basic   4,500,000    4,500,000    4,500,000 
                
The accompanying notes are an integral part of these financial statements.

 

F-10 

 

 

 

Sigmarenopro, Inc
Statement of Cash Flows
          
   For the six months ended December 31,  For the six months ended December 31,  For the six months ended December 31,
   2019  2019  2019
   (As Previously Reported)  (Restatement Adjustments)  (As Restated)
          
Cash flow from Operating Activities:               
Net loss  $(9,765)  $(4,638)  $(14,403)
Changes in Operating Assets and Liabilities:               
Increase (Decrease) in advances   —      4,638    4,638 
Increase (Decrease) in prepaid expenses   2,294    —      2,294 
Increase (Decrease) in accounts payable   100    —      100 
Net cash used in operating activities  $(7,371)  $—     $(7,371)
                
Cash flows from Investing Activities:               
Net cash flows from investing activities  $—     $—     $—   
                
Cash flows from Financing Activities:               
Net cash provided by financing activities  $—     $—     $—   
                
Net increase in cash, cash equivalents, and restricted cash  $(7,371)   —      (7,371)
Cash, cash equivalents, and restricted cash at beginning of year   17,367    —      17,367 
Cash, cash equivalents, and restricted cash at end of year  $9,996   $—     $9,996 
                
SUPPLEMENTAL CASH FLOW INFORMATION:               
Cash paid for interest  $—     $—     $—   
Cash paid for income taxes  $—     $—     $—   
                
The accompanying notes are an integral part of these financial statements.

 

NOTE I – SUBSEQUENT EVENT

 

The Company evaluated all events or transactions that occurred after September 30, 2020 through February 05, 2021. The Company determined that it does not have any subsequent event requiring recording or disclosure in the financial statements for the period ended December 31, 2020.

 

F-11 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-looking statements

 

This quarterly report on Form 10-Q contains “forward-looking statements” relating to the registrant which represent the registrant’s current expectations or beliefs, including statements concerning registrant’s operations, performance, financial condition and growth.  For this purpose, any statement contained in this quarterly report on Form 10-Q that are not statements of historical fact are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “anticipation”, “intend”, “could”, “estimate”, or “continue” or the negative or other comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, such as credit losses, dependence on management and key personnel and variability of quarterly results, ability of registrant to continue its growth strategy and competition, certain of which are beyond the registrant’s control. Should one or more of these risks or uncertainties materialize or should the underlying assumptions prove incorrect, actual outcomes and results could differ materially from those indicated in the forward-looking statements.

 

The following discussion of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes, and other financial information contained in this prospectus.

 

Overview

 

SigmaRenoPro was incorporated on June 16, 2017. Our fiscal year end is June 30, and we have no subsidiaries. Our business offices are currently located at Aloni Noa’kh St. 1, Kiryat Motzkin 26402, Israel. Omar Aamar, has served as our President, Treasurer and a director since June 16, 2017. Mr. Amar’s spouse, Hosnieh Aaman, has served as our Secretary since July 25, 2017. Mr. Aamar and Ms. Aamar collectively hold 2,300,000 shares of common stock of the Company. Mr. Aamar’s business experience is in the construction and home building industry in Israel. We are focusing on matching home project owners with contractors in the United States. Mr. Aamar, however, has no knowledge of and no experience in this business in the United States. The Company is focusing its operations in the United States because the Company’s believes the barriers to operation of its business in the United States is not burdensome and the United States has a large home repair market.

  

We plan to provide a U.S.-based service matching homeowners that have renovation projects with professionally-skilled contractors ,initially concentrating our efforts on the four consumer regions of the United States of, New York, New York; Los Angeles, California; Chicago Illinois; and Houston Texas. Our customized match making service helps homeowners converge with professional contractors. We plan to create a collection of articles intended to help homeowners with home project information, including:

 

•                     How to outline project requirements;

 

•                     How to select the right contractor;

 

•                     How to interview contractors;

 

•                     How to draw up a project contract; and

 

•                     How to settle disputes with contractors

 

Our service is deigned to be free for all homeowners to use and post their projects. We plan to build a network of professionally-skilled contractors who provide a broad array of construction and renovation services for everything from changing light fixtures to complete kitchen renovation, and from housecleaning services to new construction.

 

4

 

 

Plan of Operations

 

Comparison of the Three Months Ended December 31, 2020 and 2019

 

Lack of Revenues

 

We have limited operational history. For the three months ended December 31, 2020 and 2019 we did not generate any revenues. We anticipate that we will incur substantial losses for the foreseeable future and our ability to generate any revenues in the next 12 months continues to be uncertain.

 

Operating Expenses 

 

The Company’s operating expenses for the three months ended December 31, 2020 and 2019 were $5,936 and $3,653 respectively. Operating expenses consisted of professional fees of $5,568, general administrative expenses of $68 and share transfer agent fee of $300 for the three months ended December 31, 2020. Operating expenses consisted of professional fees of $3,403 and general administrative expenses of $45 and share transfer agent fee of $205 for the three months ended December 31, 2019.

 

Net Loss

 

During the three months ended December 31, 2020 and 2019 the Company recognized net losses of $5,936 and $3,653.

 

Comparison of the Six Months Ended December 31, 2020 and 2019

 

Lack of Revenues

 

We have limited operational history. For the six months ended December 31, 2020 and 2019 we did not generate any revenues. We anticipate that we will incur substantial losses for the foreseeable future and our ability to generate any revenues in the next 12 months continues to be uncertain.

 

Operating Expenses 

 

The Company’s operating expenses for the six months ended December 31, 2020 and 2019 were $9,545 and $14,403 respectively. Operating expenses consisted of professional fees of $8,809, general administrative expenses of $136 and share transfer agent fee of $600 for the three months ended December 31, 2020. Operating expenses consisted of professional fees of $8,894 and general administrative expenses of $5,304 and share transfer agent fee of $205 for the three months ended December 31, 2019.

 

Net Loss

 

During the three months ended December 31, 2020 and 2019 the Company recognized net losses of $9,545 and $14,403.

  

Liquidity and Capital Resources

 

Our capital resources have been acquired through the sale of shares of our common stock and loans from shareholders.

 

At December 31, 2020 and June 30, 2020, we had total assets of $10,418 and $6,404 respectively consisting of cash held in trust and prepaid expenses.

 

At December 31, 2020 and June 30, 2020, our total liabilities were $29,282 and $15,723, respectively consisting of due to related parties, short term fund and accounts payable.

 

5

 

 

Cash flows from operating activities

 

Net cash flows used in operating activities for the six month periods ended December 31, 2020 and 2019 was $(5,310) and $(7,371).

 

Going Concern

The future of our company is dependent upon its ability to obtain financing and upon future profitable operations from the sale of products and services through our websites. Management has plans to seek additional capital through a private placement and public offering of its common stock, if necessary. Our auditors have expressed a going concern opinion because uncertainties raise doubts about the Issuers ability to continue as a going concern.

 Cash Requirements

 

We intend to provide funding for our activities, if any, through a combination of the private placement of the company’s equity securities and the public sales of equity securities.

 

We have no agreement, commitment or understanding to secure any funding from any source.

 

Off-Balance Sheet Arrangements

 

We do not have any off balance sheet arrangements.  

 

Office

 

SigmaRenoPro, Inc.’s executive office is located at Aloni Noa’kh St. 1Kiryat Motzkin 26402 Israel. The telephone number is +972 03-6860331.

 

SigmaRenoPro, Inc. is not operating its business plan until such time as capital is raised for operations. To date its operation has involved only selling stock to meet expenses.

 

Business Overview

 

Since its inception, the Company derived no revenues and no income from such business and as result as of September 30, 2020, had an accumulated deficit of $86,328.

 

There is no current public market for our securities. As our stock is not publicly traded, investors should be aware they probably will be unable to sell their shares and their investment in our securities is not liquid.

 

At the present time, we are classified as a “shell company” under Rule 405 of the Securities Act Rule 12b-2 of the Exchange Act. As such, all restricted securities presently held by the affiliates of our company may not be resold in reliance on Rule 144 until: (1) we file Form 10 information with the Securities and Exchange Commission (“SEC”) when we cease to be a “shell company”; (2) we have filed all reports as required by Section 13 and 15(d) of the Securities Act for twelve consecutive months; and (3) one year has elapsed from the time we file the current Form 10 type information with the SEC reflecting our status as an entity that is not a shell company.

 

Bankruptcy Or Similar Proceedings

 

There has been no bankruptcy, receivership or similar proceeding involving the Company.

 

Number Of Total Employees And Number Of Full Time Employees

 

Omar Aamar, our sole officer and director, is our only employee, and he currently works full time on Company matters. 

Once the offering is complete we will hire additional staff if we generate enough revenue to support the expense. The number of additional staff will depend upon our growth.

 

6

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not Applicable to Smaller Reporting Companies.

 

Item 4. Controls and Procedures.

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

As required by Rule 13a-15/15d-15 under the Securities and Exchange Act of 1934,as amended (the "Exchange Act"), as of September 30, 2020, we have carried out an evaluation of the effectiveness of the design and operation of our Company's disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of our Company's management, our President (Principal Executive Officer) and Treasurer (Principal Accounting Officer). Based upon the results of that evaluation, our management has concluded that, as of September 30, 2020, our Company's disclosure controls and procedures were not effective and do not provide reasonable assurance that material information related to our Company required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management to allow timely decisions on required disclosure.

 

MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control system is designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that:

 

  Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

 

  Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

 

  Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.

 

Management assessed the effectiveness of our internal control over financial reporting as of September 30, 2020. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in INTERNAL CONTROL -- INTEGRATED FRAMEWORK.

 

Our management concluded that, as of September 30, 2020, our internal control over financial reporting was effective based on the criteria in INTERNAL CONTROL -- INTEGRATED FRAMEWORK issued by the COSO.

 

This quarterly report does not include an attestation report of the Company's independent registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's independent registered public accounting firm pursuant to rules of the SEC that permit the Company to provide only management's report in this annual report.

 

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting identified in connection with the evaluation described above during the first quarter ended September 30, 2020 that has materially affected or is reasonably likely to materially affect our internal controls over financial reporting.

 

7

 

 

PART II.  OTHER INFORMATION

 

Item 1.  Legal Proceedings.

 

SigmaRenoPro is not involved in any litigation or any material legal proceeding.  No Officer or Director is involved in any litigation or any material legal proceeding.

 

Item 1A. Risk Factors

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

 

None

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures.

 

Not Applicable

 

Item 5. Other Information.

 

None

 

Item 6. Exhibits

 

Exhibit 31.1 - Certification of Chief Executive Officer of Sigmarenopro, Inc. required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2 - Certification of Chief Financial Officer of Sigmarenopro, Inc. required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1 - Certification of Chief Executive Officer of Sigmarenopro, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63.
Exhibit 32.2 -

Certification of Chief Executive Officer of Sigmarenopro, Inc. pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63.

 

 

 

8

 

 

 

Signatures

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Sigmarenopro, Inc.  
   
By:    /s/ Omar Aamar        Date: February 05, 2021
Omar Aamar,  
President and Treasurer  

Chief Executive Officer

Chief Financial Officer

 
   

 

9